Status:
UNKNOWN
The Impact of Moderate Versus Deep Neuromuscular Blockade on Enhanced Recovery After Bariatric Anesthesia
Lead Sponsor:
King Saud University
Conditions:
Bariatric Surgery Candidate
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Most published articles suggest that deep neuromuscular blockade is required for bariatric surgery. However, the evidence for such practice is still inconclusive. From the clinical experience at a maj...
Detailed Description
Muscle relaxation is paramount for successful laparoscopic surgery. However the optimal degree of neuromuscular blockade (NMB) is not identified yet. Previous studies showed conflicting results on the...
Eligibility Criteria
Inclusion
- Age older than 18 years.
- Obese or morbidly obese as defined by a BMI \> 35 (kg/m2).
- American Society of Anesthesiologists physical status class II, or III.
- Presenting of Laparoscopic sleeve gastrectomy.
Exclusion
- History of allergy to Rocuronium or Sugammadex.
- History of allergy to Dexamethasone, Ondansetron, Paracetamol, Fentanyl, Propofol, Morphine or Tramadol.
- Current or previous pregnancy.
- History of renal impairment, (We are going to use the Cockcroft-Gault equation is the gold standard for estimating renal function for the purposes of drug dosing cut off point: CrCl/GFR=30ml/min) The GFR calculator is available at: http://clincalc.com/Kinetics/CrCl.aspx?example
- Patient on oxygen therapy , e,g CPAP
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04466943
Start Date
January 1 2020
End Date
December 31 2020
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Saud University College of Medicine and King Khalid University Hospital
Riyadh, Saudi Arabia, 11472